Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Imani Therapeutics AB
AB
Active
Org 5591949093
Hägervägen 27, 746 34
Bålsta
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2019
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Imani Therapeutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
-2M
2020
-2M
2021
-1M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−1 709
−1 776
−525
−89
−2
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−1 709
−1 776
−525
−89
−2
Net financials
—
—
—
—
—
Profit before tax
−1 709
−1 776
−525
−89
−2
Tax
−0
−0
−0
−0
−0
Net profit
−1 709
−1 776
−525
−89
−2
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 341
1 123
214
1 086
1 250
Equity
989
739
214
185
230
Long-term debt
0
0
0
0
966
Short-term debt
352
384
0
902
53
Total debt
352
384
—
902
1 019
Financial ratios
5-year trend
EBITDA margin
-200000.0%
This company
15.8%
Market median
-1265923% vs market
2020
2024
Equity ratio
18.4%
This company
38.2%
Market median
-52% vs market
2020
2024
Return on equity
-0.9%
This company
18.4%
Market median
-105% vs market
2020
2024
Net profit margin
-200000.0%
This company
8.1%
Market median
-2469236% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
4.43×
This company
0.62×
Market median
-615% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Imani Therapeutics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
